RETAGLIPTIN
UNII 328C4R3P9L

Substance Identification & Data

This profile provides standardized clinical and technical data for Retagliptin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 328C4R3P9L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1174122-54-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

328C4R3P9L

CAS Registry Number

1174122-54-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RETAGLIPTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H18F6N4O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WIIAMRXFUJLYEF-SNVBAGLBSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C223504

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

44193830

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c(c(cc(C[C@H](CC(N2Cc3n(c(nc3C(OC)=O)C(F)(F)F)CC2)=O)N)c1F)F)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Retagliptin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.